Autor: "Yang YC" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: [The efficacy of chemotherapy re-challenge in third-line setting for metastatic colorectal cancer patients: a real-world study].
Autorzy:: Duan JJ; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Ning T; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Bai M; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Zhang L; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Li HL; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Liu R; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Ge SH; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Wang X; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Yang YC; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Ji Z; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Wang FX; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Sun YS; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Ba Y; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Deng T; Department of GI Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Nov 23; Vol. 45 (11), pp. 967-972.
Typ publikacji:: English Abstract; Journal Article
MeSH Terms:: Colorectal Neoplasms*/pathology
Colonic Neoplasms*/chemically induced
Rectal Neoplasms*/drug therapy
Humans ; Irinotecan/therapeutic use ; Oxaliplatin/therapeutic use ; Retrospective Studies ; Fluorouracil ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: [Therapeutic effect of Jin Long capsule combined with neoadjuvant chemotherapy on invasive breast cancer and the expression change of multidrug resistance proteins].
Autorzy:: Yang TY; Department of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Yi W; Department of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Wen J; Department of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Gan CY; Department of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Yang YC; Department of Pathology, Guizhou Provincial People's Hospital, Guiyang 550002, China.
Dai M; Department of Breast Surgery, Guizhou Provincial People's Hospital, Guiyang 550002, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2019 Feb 23; Vol. 41 (2), pp. 118-123.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Neoadjuvant Therapy*/adverse effects
ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Breast Neoplasms/*metabolism
Drugs, Chinese Herbal/*therapeutic use
ATP Binding Cassette Transporter, Subfamily B ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/pathology ; Capsules ; Chemotherapy, Adjuvant/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; DNA Topoisomerases, Type II/metabolism ; Etoposide/administration & dosage ; Etoposide/adverse effects ; Female ; Glutathione Transferase/metabolism ; Humans ; Taxoids/administration & dosage ; Taxoids/adverse effects
SCR Protocol:: TEC protocol

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Yang YC"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat